Disease model | Scoring system: parameters (scale width) | Citations |
---|---|---|
Stroke | ||
Focal ischemia [62] | Ischemic neuronal damage (0–3) | 2176 |
Focal Ischemia[63] | 18 areas x neuronal injury (0–5) | 23 |
Global ischemia [64] | Infarcts in 3 cerebral regions (0–4), hippocampus infarction (0–4) | 100 |
Global ischemia [65] | Eight regions x neuronal cell los/gliosis/iron deposition/gliosis (0–3) | 95 |
Peripheral nerve ischemia [66] | Edema, fiber regeneration (each 0–4) | 21 |
Multiple sclerosis models | ||
EAE [67] | Inflammation, neuronal degeneration (each 0–4) | 160 |
EAE [68] | Inflammation (cells/cuff), axonal injury, axonal loss (each 0–4) | 81 |
EAE[69] | Lesion severity, myelin loss/tissue injury, acute inflammation, chronic inflammation (each 0–5) | 79 |
Theiler's murine encephalomyelitis virus [70] | Neuropil inflammation, demyelination, necrosis, meningeal inflammation (each 0–4) | 77 |
EAE [71] | Infiltration, demyelination (together 0,1) in 16 regions | 64 |
EAE [72] | Inflammation, necrosis (each 0–3) | 53 |
EAE [73] | Inflammation (cuffs/100 m2), demyelination (lesions/mm2) | 52 |
EAE [74] | Meningitis (0–2), perivascular cuffing (0–5), demyelination (0–3) | 43 |
EAE [75] | Spinal cord demyelination (0–3), inflammatory cells (No./mm2) | 22 |
Spinal cord trauma (SCT) | ||
SCT [76] | Gray matter degeneration/infarction (0–4) in 5 μm serial sections | 33 |
SCT [77] | 150 μm intervals x Area affected by neuronal degeneration, malacia (0–4) | 23 |
Encephalitis/Meningitis | Â | Â |
Streptococcus meningitis [78] | Meningeal inflammation (0–3) x four regions | 46 |
Trypanosoma encephalitis [79] | Meningitis, perivascular cuffing, neuropil infiltration (each 0–4) | 41 |
Miscellaneous CNS diseases | ||
Oxidative damage [80] | 7 areas x necrosis (0–3) | 27 |
Senescence [81] | Spongiosis (0–3), lipofuscin positive cells (%) | 23 |
Spinocerebellar ataxia [82] | Molecular layer thickness, Purkinje cell loss (each 0–3) | 10 |